AP NEWS

Worldwide Antifungal Drugs Market (2018-2022) to Register a CAGR of Over 3% - Astellas Pharma, Basilea Pharmaceutica, Merck and Pfizer are the Dominant Vendors - ResearchAndMarkets.com

January 4, 2019

DUBLIN--(BUSINESS WIRE)--Jan 4, 2019--The “Global Antifungal Drugs Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering.

The antifungal drugs market is projected to register a CAGR of over 3% by 2022.

Use of antifungal infections is expected to drive growth in the market

Research has shown synergism between many antifungals, which has led to an increase in clinicians prescribing combination therapies over monotherapies. Also, availability of antifungals with novel mechanisms of actions has promoted the trend of using combinations.

Increase in antifungal research funding

An increase in funding for antifungal research is another key factor contributing to the growth of the global antifungal drugs market. In many European countries, government funding is also available for research in fungal diseases.

Diagnostic challenges due to non-specific symptoms

Antifungals are often associated with mild adverse effects like itching, redness, abdominal pain, and diarrhea.

Key Players

Astellas Pharma Basilea Pharmaceutica Merck Pfizer

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

Market ecosystem Market characteristics Market segmentation analysis

PART 05: PIPELINE ANALYSIS

PART 06: MARKET SIZING

Market definition Market sizing 2017 Market size and forecast 2017-2022

PART 07: FIVE FORCES ANALYSIS

PART 08: MARKET SEGMENTATION BY ROUTE OF ADMINISTRATION

Segmentation by route of administration Comparison by route of administration Topical - Market size and forecast 2017-2022 Oral - Market size and forecast 2017-2022 Parenteral - Market size and forecast 2017-2022 Market opportunity by product

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE

Geographical segmentation Regional comparison Americas - Market size and forecast 2017-2022 EMEA - Market size and forecast 2017-2022 APAC - Market size and forecast 2017-2022 Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE

Overview Landscape disruption Vendors covered

PART 15: VENDOR ANALYSIS

Market positioning of vendors Astellas Pharma Basilea Pharmaceutica Merck Pfizer

For more information about this report visit https://www.researchandmarkets.com/research/6x3cx8/worldwide?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190104005393/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infectious Diseases Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/04/2019 11:20 AM/DISC: 01/04/2019 11:20 AM

http://www.businesswire.com/news/home/20190104005393/en

AP RADIO
Update hourly